These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

594 related items for PubMed ID: 6392343

  • 21. Characterization of natural killer activity in sponge matrix allografts.
    Hoffman RA, Ascher NL, Jordan ML, Migliori RJ, Simmons RL.
    J Immunol; 1988 Mar 01; 140(5):1702-10. PubMed ID: 3257981
    [Abstract] [Full Text] [Related]

  • 22. Induction of nonspecific cytotoxicity by monoclonal anti-T3 antibodies.
    Leeuwenberg JF, Spits H, Tax WJ, Capel PJ.
    J Immunol; 1985 Jun 01; 134(6):3770-5. PubMed ID: 2580895
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones.
    Schmidt RE, Hercend T, Fox DA, Bensussan A, Bartley G, Daley JF, Schlossman SF, Reinherz EL, Ritz J.
    J Immunol; 1985 Jul 01; 135(1):672-8. PubMed ID: 3923116
    [Abstract] [Full Text] [Related]

  • 25. Analysis of rat natural killer cytotoxic factor (NKCF) produced by rat NK cell lines and the production of a murine monoclonal antibody that neutralizes NKCF.
    Ortaldo JR, Winkler-Pickett R, Morgan AC, Woodhouse C, Kantor R, Reynolds CW.
    J Immunol; 1987 Nov 01; 139(9):3159-65. PubMed ID: 3668253
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Analysis of the cytolytic activity mediated by natural killer cells from acquired immunodeficiency syndrome patients in response to phytohemagglutinin or anti-CD16 monoclonal antibody.
    Sirianni MC, Mezzaroma I, Aiuti F, Moretta A.
    Eur J Immunol; 1994 Aug 01; 24(8):1874-8. PubMed ID: 8056046
    [Abstract] [Full Text] [Related]

  • 29. Augmentation by anti-T3 antibody of the lymphokine-activated killer cell-mediated cytotoxicity.
    Ting CC, Hargrove ME, Yun YS.
    J Immunol; 1988 Aug 01; 141(3):741-8. PubMed ID: 3260909
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I. Defective trigger on NK cells for NKCF production by target cells, and partial restoration by IL 2.
    Bonavida B, Katz J, Gottlieb M.
    J Immunol; 1986 Aug 15; 137(4):1157-63. PubMed ID: 3488345
    [Abstract] [Full Text] [Related]

  • 32. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
    Brunda MJ, Taramelli D, Holden HT, Varesio L.
    J Immunol; 1983 Apr 15; 130(4):1974-9. PubMed ID: 6187831
    [Abstract] [Full Text] [Related]

  • 33. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M, Hasegawa H, Nakayabu M, Fukai K, Suzuki S.
    J Clin Lab Immunol; 1993 Apr 15; 40(2):47-60. PubMed ID: 7932628
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A novel type of human T cell clone with highly potent natural killer-like cytotoxicity divorced from large granular lymphocyte morphology.
    Schneider EM, Pawelec GP, Liangru S, Wernet P.
    J Immunol; 1984 Jul 15; 133(1):173-9. PubMed ID: 6609974
    [Abstract] [Full Text] [Related]

  • 36. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F, Peri G, Villa A, Mantovani A.
    J Immunol; 1984 Feb 15; 132(2):936-44. PubMed ID: 6690624
    [Abstract] [Full Text] [Related]

  • 37. A monoclonal antibody reactive with a 15-kDa cytoplasmic granule-associated protein defines a subpopulation of CD8+ T lymphocytes.
    Anderson P, Nagler-Anderson C, O'Brien C, Levine H, Watkins S, Slayter HS, Blue ML, Schlossman SF.
    J Immunol; 1990 Jan 15; 144(2):574-82. PubMed ID: 2104899
    [Abstract] [Full Text] [Related]

  • 38. Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity.
    Kuroki M, Hachimine K, Huang J, Shibaguchi H, Kinugasa T, Maekawa S, Kuroki M.
    Anticancer Res; 2005 Jan 15; 25(6A):3725-32. PubMed ID: 16302732
    [Abstract] [Full Text] [Related]

  • 39. Frequent T4-positive cells with cytolytic activity in spleens of patients with Hodgkin's disease (a clonal analysis).
    Maggi E, Parronchi P, Del Prete G, Ricci M, Bosi A, Moretta L, Romagnani S.
    J Immunol; 1986 Feb 15; 136(4):1516-20. PubMed ID: 3080527
    [Abstract] [Full Text] [Related]

  • 40. Monocyte-mediated augmentation of human natural killer cell activity: conditions, monocyte and effector cell characteristics.
    Bloom ET, Babbitt JT, Kawakami K.
    J Immunol; 1986 Jul 01; 137(1):172-8. PubMed ID: 3711665
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.